SARS-CoV-2 SPIKE Antibody Levels can Indicate Immuno-Resilience to Re-infection: a Real-World Study
Abstract Introduction The use of antibody titers against SARS-CoV-2, as a method of estimating subsequent infection following infection or vaccination, is unclear. Here, we investigate whether specific levels of antibodies, as markers of adaptive immunity, can serve to estimate the risk of symptomat...
Saved in:
| Main Authors: | Yue Jin, Fei Yang, Christopher M. Rank, Stanley Letovsky, Peter Ramge, Simon Jochum |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2024-12-01
|
| Series: | Infectious Diseases and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40121-024-01090-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SARS‐CoV‐2 spike glycoprotein‐reactive T cells can be readily expanded from COVID‐19 vaccinated donors
by: Pavla Taborska, et al.
Published: (2021-12-01) -
Seroprevalence of SARS-COV-2 antibodies among school-age children in the Swabi district of Pakistan
by: Muhammad Arif, et al.
Published: (2024-03-01) -
Immune age is correlated with decreased TCR clonal diversity and antibody response to SARS-CoV-2
by: Merlin Davies, et al.
Published: (2025-06-01) -
Immunogenicity of intranasal vaccine based on SARS-CoV-2 spike protein during primary and booster immunizations in mice
by: Huijie Yang, et al.
Published: (2024-12-01) -
Evaluating SARS-CoV-2 T Cell Immunity in COVID-19-Naive Vaccinated Individuals with and Without Spike Protein IgG Antibodies
by: Vassiliki C. Pitiriga, et al.
Published: (2025-04-01)